STOCKTON, CALIFORNIA/March ,82013/ Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for an exclusive license from Health Care Intellectual Properties, LLC, to Viratech, Corp, of United States Provisional Patent Application 61724948, titled “Method of Making and Tracking Benefits of a Women’s Wellness Formula.”
This patent-pending technology consists of a formula and method of testing that may assist to establish homeostasis (body balance) for women’s health. Dr. Buckman, CEO of Viratech, states, “Breast cancer, breast disease, uterine and cervical cancer are common deadly problems in women. Early diagnosis, prevention, and treatments are vital for better outcomes.”
This provisional patent was designed to assist with helping women with a wellness formula and lab tests based on scientific studies. Further studies are needed to assess the importance of testing and treating hormonal imbalances, chemical imbalances, and oxidative stress in female related disorders.
Health Care Intellectual Properties is the holding company for Dr. Buckman’s patents licensed to Viratech on an exclusive basis. This will also allow Viratech to sub-license this technology to other companies.
Dr. Buckman has written a variety of books: Find and Stop Breast Cancer, Find and Stop Diabetes, Find and Stop Body Imbalances, The Wellness Index, and other books on cancer.
Viratech has a platform that can help with new technologies for licensing, sublicensing, promotion, business development, and marketing. Using this model, Viratech anticipates sublicensing of the technologies from this agreement to support its model of light-touch, low overhead, and making a difference for women’s health. Viratech is interested in using its open-source research platform to further research in this field.
About Viratech Corp.
Viratech Corp. has created the first open source biotech research social network platform. The purpose of the platform is to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. This has been made possible by leveraging social collaboration in a way that allows new biotech ventures the ability to protect their intellectual property, then simultaneously allowing those same ventures the ability to promote and crowdsource their development.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Dr. Kevin Buckman
Viratech, Corp.
http://viratech.org
Email Contact: info@viratech.org
209-477-3030